AstraZeneca

As one of the world's leading pharmaceutical companies, AstraZeneca provides innovative, effective medicines that make a real difference in important areas of healthcare.

No of Employees:

65,000 worldwide

Chief Executive Officer:

David Brennan

Sales:

$23,950 million

Operating Profit:

$6.5 billion

Through the innovation and production of new medicines, AstraZeneca improves human health and enhances people’s lives. Its activities affect not just the patients they serve and investors, but also their employees and society as a whole.  With over 65,000 employees across the globe, their focus is on important areas of medical need - cancer, cardiovascular, gastrointestinal, infection, neuroscience and respiratory & inflammation.

Backed by a strong research base and extensive commercial skills, AstraZeneca manufactures its products in 20 countries and sells in over 100. In the UK there are eight principal sites - including a corporate office in London.

AstraZeneca’s reputation and continued long term success depend on their ability to successfully integrate their financial obligations with their social and environmental responsibilities. In so doing, they aim to maintain the trust and confidence of their stakeholders and continue to be a company that is welcomed by society and for which their employees are proud to work.